Previous 10 | Next 10 |
home / stock / bayzf / bayzf news
2023-11-29 15:03:50 ET Prominent activist investor Jeff Ubben is shutting down his social investing-focused firm, Inclusive Capital Partners. Inclusive Capital has started to wind down its operations and is returning capital to limited partners, acording to a WSJ report on Wednesday...
2023-11-27 15:13:46 ET More on Bayer AG Breaking Up Bayer? Probably Not! Bayer Aktiengesellschaft 2023 Q3 - Results - Earnings Call Presentation Bayer Aktiengesellschaft (BAYZF) Q3 2023 Earnings Call Transcript Bayer denies knowledge of trial results before $...
2023-11-24 07:28:45 ET More on Bayer, Bayer AG, etc. Breaking Up Bayer? Probably Not! Bayer Aktiengesellschaft 2023 Q3 - Results - Earnings Call Presentation Bayer Aktiengesellschaft (BAYZF) Q3 2023 Earnings Call Transcript Bayer ordered to pay $375M in Washi...
2023-11-22 07:24:12 ET More on Bayer Breaking Up Bayer? Probably Not! Bayer Aktiengesellschaft 2023 Q3 - Results - Earnings Call Presentation Bayer Aktiengesellschaft (BAYZF) Q3 2023 Earnings Call Transcript Bayer says blood thinner failed in Phase 3 trial ...
2023-11-20 08:48:57 ET More on Bayer Breaking Up Bayer? Probably Not! Bayer Aktiengesellschaft 2023 Q3 - Results - Earnings Call Presentation Bayer Aktiengesellschaft (BAYZF) Q3 2023 Earnings Call Transcript Bayer told to pay $1.56B in latest Roundup lawsuit ...
2023-11-20 07:14:14 ET More on Bayer Breaking Up Bayer? Probably Not! Bayer Aktiengesellschaft 2023 Q3 - Results - Earnings Call Presentation Bayer Aktiengesellschaft (BAYZF) Q3 2023 Earnings Call Transcript EU to extend glyphosate use for 10 more years after...
2023-11-16 13:09:47 ET More on Bayer Breaking Up Bayer? Probably Not! Bayer Aktiengesellschaft 2023 Q3 - Results - Earnings Call Presentation Bayer Aktiengesellschaft (BAYZF) Q3 2023 Earnings Call Transcript Bayer pulling lymphoma drug from US market over fai...
2023-11-16 12:35:07 ET Summary Recursion Pharmaceuticals, Inc. proof-of-concept data, from the phase 2 SYCAMORE study using REC-994 for the treatment of patients with Cerebral Cavernous Malformation, expected in the 2nd half of 2024. Safety and preliminary efficacy data, from the ...
2023-11-15 08:10:00 ET Summary S&P 500 and Dow Jones dropped for the third straight month in October, just before staging a remarkable reversal in November. Interest rates were kept steady again in a range of 5.25% to 5.5%, and it is uncertain if 2023 will see yet another hike...
2023-11-13 17:03:00 ET More on Bayer Breaking Up Bayer? Probably Not! Bayer Aktiengesellschaft 2023 Q3 - Results - Earnings Call Presentation Bayer Aktiengesellschaft (BAYZF) Q3 2023 Earnings Call Transcript Bayer considering breakup but not immediate three-w...
News, Short Squeeze, Breakout and More Instantly...
Bayer AG Registered Shares Company Name:
BAYZF Stock Symbol:
OTCMKTS Market:
NORTHAMPTON, MA / ACCESSWIRE / August 29, 2023 / Bayer - As climate change quickens, societal expectations increase and the threat of resistance grows, new crop protection solutions are imperative. Advances in the life sciences and data-driven technologies hold the key to expanding our pipeline ...
Monsanto Must Face Georgia State Jurors in Lawsuit Over Cancer-Causing Roundup Herbicide PR Newswire 11th Circuit opinion finds chemical giant subject to state's warning label laws Nachawati Law Group trial lawyers gearing up for next Roundup cancer trial in Au...
Bayer Runs Out of Appeals at US Supreme Court as Thousands of Cancer Lawsuits Await over Roundup Herbicide PR Newswire Fears Nachawati trial lawyers gearing up for next Roundup cancer trial in August WASHINGTON , June 22, 2022 /PRNewswire/ -- Baye...